News

Prevent-Plus Announces the Full US Commercial Launch of Preventogen in Partnership with ARC Group Medical

The application of the PREVENTOGEN liquid polymer in pre-launch clinical studies has shown its effectiveness in dramatically reducing the rate…

2 years ago

IMPLANET Reports Its Revenue for Q2 2022, Up 33%

Q2 2022 revenue growth of +33% to €2.1 million (vs. Q2 2021) Revenue for the first half of 2022 up…

2 years ago

ModMed® CEO and Cofounder Daniel Cane Earns Place on The Healthcare Technology Report’s ‘Top 50 Healthcare Technology CEOs of 2022’ List

The award recognizes some of the most accomplished executives in the healthcare technology industry BOCA RATON, Fla.--(BUSINESS WIRE)--ModMed® announced today…

2 years ago

Meet Nanomerics CSO in Montreal This Summer – Nanomerics CSO to Give Plenary Lecture at Controlled Release Society Annual Meeting and Expo in Montreal on 13th July 2022

LONDON, UK / ACCESSWIRE / July 11, 2022 /  Nanomerics Ltd., a private speciality pharmaceutical company, today announced that Nanomerics' Chief…

2 years ago

Rushnet, Inc. and heliosDX Launch AutoUA(R) Testing to Enhance Patient Care and Help Prevent Kidney Disease Among Other Conditions including UTI

ALPHARETTA, GA / ACCESSWIRE / July 11, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce that…

2 years ago

Poko Regenerating Collagen Moisturizer and Brightening Rosewater Toner Win Editor’s Prize at the Beauty Shortlist Mama & Baby Awards

Free From Skincare Awards 2022 to Be Announced July 19LONDON, UK and DUBLIN, IRELAND / ACCESSWIRE / July 11, 2022…

2 years ago

SafeHeal Appoints Medical Device Industry Veteran Chris Richardson as Chief Executive Officer

PARIS, FRANCE and TAMPA, FL / ACCESSWIRE / July 11, 2022 / SafeHeal, a leading innovator in the field of…

2 years ago

Moderna’s Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized Booster

mRNA-1273.214 has now demonstrated significantly higher antibody titers against all tested variants, including Omicron BA.1 and BA.4/5 subvariants, ancestral virus,…

2 years ago

Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation

SANTA BARBARA, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a leading medical…

2 years ago

CytoDyn Highlights NIH Grant for HIV Functional Cure Preclinical Study of Gene Therapy Based on Leronlimab

$5 Million Grant Awarded to OHSU for Preclinical Research of One-time Injection of Gene Therapy Based on Leronlimab for Functional…

2 years ago